Kindred Biosciences Announces Plans for Promotion of Dr. Zhan and Retirement of Dr. Sundlof

San Francisco, CA (September 11, 2017) Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that Dr. Stephen Sundlof will retire in January of 2018 and that, simultaneous with his retirement, Dr. Hangjun Zhan will be promoted to the position of Chief Scientific Officer. Dr. […]

Kindred Biosciences to Present at Upcoming Investor Conferences

San Francisco, CA (August 30, 2017) Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that it will be presenting at three, upcoming investor conferences in September 2017: 6th Annual Gateway Conference (September 6-7, 2017). Location: Four Seasons Hotel, San Francisco, CA Presentation Date and […]

Kindred Biosciences Announces Second Quarter 2017 Financial Results

San Francisco, CA (August 7, 2017) Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced financial results for the second quarter ended June 30, 2017 and provided updates on its programs. “We continue to look forward to our two upcoming approvals and launches. The commercial […]

Kindred Biosciences Sponsors Veterinary Students to Attend the 2017 American Association of Feline Practitioners Meeting

Kindred Biosciences Sponsors Veterinary Students to Attend the 2017 American Association of Feline Practitioners Meeting San Francisco, CA (August 4, 2017) Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that it will be sponsoring twenty veterinary students to attend the 2017 American Association of […]

Kindred Biosciences to Announce Second Quarter 2017 Financial Results

Kindred Biosciences to Announce Second Quarter 2017 Financial Results Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time on Monday, August 7, 2017 San Francisco, CA (July 24, 2017) Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today […]